Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density.

blosozumab (LY2541546) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42747328

Feng Shao; Hua Lin; Lu Wang; Sufeng Zhou; Xiufen Zhu; Yuchen Sheng

Sep 17, 2026